Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment.
ESC Heart Fail
; 7(6): 4367-4370, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-871353
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a global pandemic increasingly encountered in the clinical setting. It typically manifests as a respiratory illness, although cardiac involvement is common and portends a worse prognosis. We present the case of a 56-year-old male admitted with COVID-19 fulminant myocarditis and cardiogenic shock. We discuss important aspects of the multidisciplinary and interventional care involved in treating cardiogenic shock as well as the likely mechanisms of, and potential treatment for, COVID-19 myocarditis. The various pathways of myocardial injury, including direct viral damage, macrophage activation, and lymphocytic infiltration, are outlined in detail in addition to associated pathology such as cytokine release syndrome. COVID-19 is a complex and multisystem disease process; in addition to supportive care, specific consideration should be given to the underlying mechanism of injury for each patient.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
ESC Heart Fail
Year:
2020
Document Type:
Article
Affiliation country:
Ehf2.13041
Similar
MEDLINE
...
LILACS
LIS